1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
AREV Life Sciences Global Corp.

AREV Life Sciences Global Corp.

AREV.CN
AREV Life Sciences Global Corp.CA flagCanadian Securities Exchange
0.09
CAD
- -
- -
2.84MMarket Cap
AREV Life Sciences Global Corp.
AREV.CN
(Canadian Securities Exchange)

Recent

price

0.09

P/E

ratio

- -

div

yld

- -

ROIC.AI

2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
TTM
FRC
50.83
- -
6.69
16.36
- -
- -
- -
- -
- -
- -
- -
0.02
0.01
0.01
- -
- -
Revenue per Share
-37.97
-38.28
-2.8
9.75
-7.57
-6.23
-13.07
-16.45
-24.4
-0.42
-1.44
-0.36
-0.07
-0.05
-0.05
-0.01
Basic EPS, GAAP
-45.66
-12.86
-3.68
1.55
2.31
-5.25
-0.72
-10.12
-11.23
-0.23
-0.2
-0.04
-0.03
-0.08
-0.01
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-154.4
-192.68
-195.48
-172.57
-176.4
-215.32
-217.2
-260.77
-153.8
0.18
-0.21
-0.31
-0.2
-0.15
-0.13
-0.13
Book Value per Share
36.05
1.14
-1.66
12.33
4.49
-0.91
-13.93
-32.12
3.38
0.4
-0.01
-0.06
-0.04
- -
-0.03
-0.04
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
6
9
15
20
30
32
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
-76.71
- -
-112.27
59.84
- -
- -
- -
- -
- -
- -
- -
-1,554.39
-342.72
-653.59
-2,839.86
-2,919.02
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1
-8
-3
-1
-1
-1
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-74.69
- -
-41.8
59.6
- -
- -
- -
- -
- -
- -
- -
-1,639.99
-550.37
-388.36
-2,940.37
-3,322.8
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1
-1
- -
-1
-1
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
-1
-1
- -
-1
-1
Total Equity
- -
- -
- -
129.59
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
-5.58
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
41.53
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'23
Jun'23
Sep'23
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
32
32
32
Market Capitalization
6
4
3

Working Capital

FRC

•

in mil. unless spec.
Mar'23
Jun'23
Sep'23
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
1
1
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
316.75%
290.45%
918.75%
Free Cash Flow
152.6%
49.48%
-76.15%
Net Income, GAAP
122.9%
124.43%
45.82%
Sales/Revenue/Turnover
- -
- -
-80.74%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
-0.03
-0.03
-0.01
- -
-0.05
2022
-0.02
-0.03
-0.01
- -
-0.05
2023
-0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2021
- -
- -
- -
- -
- -
2022
- -
- -
- -
- -
- -
2023
- -
- -
- -
- -
- -
Similar Companies
Ortin Laboratories Limited (ORTINLAABS.BO)
Peak Fpo [pkp] (PKP.AX)
Lords & Company Worldwide Holdings Inc. (LRDSF)
Ind-Swift Limited (INDSWFTLTD.BO)
Theratechnologies Inc. (THTX)
Live Verdure Ltd (LV1.AX)
Business
AREV Life Sciences Global Corp. (AREV.CN) operates as an early-stage life science discovery company focused on producing and selling functional ingredients via proprietary extraction systems for the nutraceutical, natural health, medical, functional food, sport nutrition, and pet markets. The company offers nutraceutical formulations under its BARE and Wright & Well brands, including cannabidiol-infused products such as Canna-Mulsion and NaturVax anti-viral supplement; NaturRelax natural sleep aid; NaturRelief anti-inflammatory and pain relief product; CBD skincare products; medicinal oils and edibles; toll-processed essential and functional oils; and pipeline products like SUS-TAINN Ready-to-Use Therapeutic Food for Severe Acute Malnutrition and RESTORE enteral formula for clinical nutrition needs. Founded in 1986 and headquartered at 91 Golden Drive, Unit 18, Coquitlam, British Columbia, Canada, AREV conducts operations primarily in Canada with toll processing and distribution channels extending internationally. In recent developments, the company acquired Wright & Well Essentials Inc. in 2021 to expand its therapeutic wellness offerings in the US and Canadian markets, and it changed its name to AREV Life Sciences Global Corp. to reflect its focus on life sciences innovation.